Newsroom

Sorted by: Latest

-

OneSpaWorld Announces Second Quarter Fiscal 2026 Financial Results on July 29, 2026

NEW YORK--(BUSINESS WIRE)--OneSpaWorld Holdings Limited, (NASDAQ: OSW), the pre-eminent global provider of health and wellness products and services on board cruise ships and in destination resorts around the world, announced today that it will release its Second Quarter Fiscal 2026 earnings on Wednesday, July 29th before market open. The Company will conduct a conference call the same day at 10:00 am ET to discuss its quarterly results. What: OneSpaWorld Second Quarter Fiscal 2026 financial re...
-

BankUnited, Inc. Reports 2Q 2026 Net Income of $71 million, $0.97 Diluted EPS

MIAMI LAKES, Fla.--(BUSINESS WIRE)--BankUnited, Inc. Reports 2Q 2026 Results...
-

RPM Reports Record Fiscal 2026 Fourth-Quarter and Full-Year Results

MEDINA, Ohio--(BUSINESS WIRE)--RPM Reports Record Fiscal 2026 Fourth-Quarter and Full-Year Results...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 21.07.2026 FEUZ IE00B8X9NY41 1,638,642.00 EUR 106,739,175.90   65.139  ...
-

Skip Hop Launches Clean Slate Rescue to Help Parents Navigate Stressful Diaper Changes This Summer

NEW YORK--(BUSINESS WIRE)--As summer travel and family outings ramp up, so do diaper changes away from home. While getting out of the house with a baby is an adventure in itself, new research says changing diapers in public remains one of the most stressful parts of being on the go. New findings from Skip Hop reveal that 60% of parents find diaper changes in public stressful, with nearly 40% delaying diaper changes to avoid using public changing tables. Nearly one in four parents have even cut...
-

PulteGroup Reports Second Quarter 2026 Financial Results

ATLANTA--(BUSINESS WIRE)--PulteGroup, Inc. (NYSE: PHM) announced today financial results for its second quarter ended June 30, 2026. For the quarter, the Company reported net income of $472 million, or $2.48 per share. In the prior year period, the Company reported net income of $608 million, or $3.03 per share. “We continue to capture benefits from our return-focused operating model and business platform that is well diversified across markets and buyer groups,” said Ryan Marshall, President a...
-

Wabtec Reports Strong Second Quarter 2026 Results, Announces Increase to Full-Year Revenue & Adjusted EPS Guidance

PITTSBURGH--(BUSINESS WIRE)--Wabtec Corporation (NYSE: WAB) today reported second quarter 2026 GAAP earnings per diluted share of $2.33, up 18.9% versus the second quarter of 2025. Adjusted earnings per diluted share were $2.76, up 21.6% versus the same quarter a year ago. Second quarter sales were $3.18 billion and cash from operations was $441 million. “Wabtec delivered a strong first half, with solid second quarter execution across our businesses driving robust sales growth, margin expansion...
-

Travel + Leisure Co. Reports Second Quarter 2026 Results

ORLANDO, Fla.--(BUSINESS WIRE)--Travel + Leisure Co. (NYSE:TNL), a leading leisure travel company, today reported second quarter 2026 financial results for the three months ended June 30, 2026. Highlights and outlook include: Net revenue of $1.06 billion. Gross VOI sales of $693 million, up 4% and 6% year-over-year, respectively(1) Net income of $109 million (diluted earnings per share of $1.72) Adjusted EBITDA of $269 million and Adjusted diluted earnings per share of $1.88, representing 8% an...
-

Ivonescimab Plus Chemotherapy Shows Consistent, Favorable Overall Survival Results in Western and Asian Patients in Updated Analysis from Global Phase III HARMONi Study

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (Nasdaq: SMMT) today announced results of an updated overall survival (OS) analysis from the global Phase III HARMONi clinical trial featuring the novel, potential first-in-class investigational bispecific antibody ivonescimab. Ivonescimab plus platinum-doublet chemotherapy in this trial continues to show a positive OS trend and a consistent efficacy and safety profile in Asian and western patients when compared to chemotherapy alone. The HARMONi...
-

كشفت منصة التجارة الإلكترونية العابرة للحدود اليابانية "WAFUU.COM" عن شخصية التميمة الرسمية "Mochi"

طوكيو--(BUSINESS WIRE)--يسر شركة .QRESTIA Inc (التي يقع مقرها الرئيسي في: شيبويا، بطوكيو؛ ورئيسها ومديرها التنفيذي: Hidemasa Fukada) أن تعلن أن WAFUU.COM، موقع التجارة الإلكترونية عبر الحدود، قد كشف النقاب عن شخصية التميمة الرسمية الجديدة، Mochi. ستمثل Mochi دفء WAFUU.COM وودها عبر موقعها على الويب ووسائل التواصل الاجتماعي والحملات وإدراج الحزم والمواد الإبداعية الأخرى، والتواصل مع المعجبين في كل مكان.يتناول هذا البيان الصحفي الوسائط المتعددة. يمكنك الاطلاع على البيان كاملاً هنا: https://www.bus...